Search
for
Sort by
Research 61–90 of 1000+
- Preliminary Toxicity Profile of Arotinoids SMR-2 and SMR-6 in Male B6D2F1 Mice
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Hepatotoxicity Secondary to A Drug to Lose Weight, "Orlistat": to take into Account as a Differential Diagnosis
- S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Recurrence of Pemphigus Vulgaris Associated With Interleukin 2 Therapy
- The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia
- Poster Abstracts
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Toxicity of the immune suppressant cyclosporin A in the rat
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Nutrition and hair
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Androgens in women
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Prophylaxis and Management of Skin Toxicities
- Toxicity Assessment of a Single Dose of Poly(ethylene glycol) Diglycidyl Ether (PEGDE) Administered Subcutaneously in Mice
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Alopecia Associated with Fluconazole Therapy
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Safety assessment of <i>Linum usitatissimum</i> (Linn.) Ingestion in New Zealand rabbits
- Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- Bioavailability File: Bicalutamide
- Ethylene glycol toxicity in two calves
- Agent: Minoxidil
- Cystoid macular oedema in uveitis: An unsolved problem
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus